Welcure Drugs & Pharmaceuticals Limited
Prices are adjusted according to historical splits.
Vitals
- Today's Low:
- ₹3.8
- Today's High:
- ₹3.9
- Open Price:
- ₹3.82
- 52W Low:
- ₹3.31
- 52W High:
- ₹10.95
- Prev. Close:
- ₹3.82
- Volume:
- 38056
Company Statistics
- Market Cap.:
- ₹27.56 million
- Book Value:
- 0.035
- Revenue TTM:
- ₹913000
- Operating Margin TTM:
- 1.1%
- Gross Profit TTM:
- ₹825000
- Profit Margin:
- 2.05%
- Return on Assets TTM:
- 1.64%
- Return on Equity TTM:
- 5.73%
Company Profile
Welcure Drugs & Pharmaceuticals Limited had its IPO on under the ticker symbol 524661.
The company operates in the Other sector and Other industry. Welcure Drugs & Pharmaceuticals Limited has a staff strength of 0 employees.
Stock update
Shares of Welcure Drugs & Pharmaceuticals Limited opened at ₹3.82 at the start of the last trading session i.e. 2023-09-13.
The stocks traded within a range of ₹3.8 - ₹3.9, and closed at ₹3.8.
This is a -0.52% slip from the previous day's closing price.
A total volume of 38,056 shares were traded at the close of the day’s session.
In the last one week, shares of Welcure Drugs & Pharmaceuticals Limited have increased by +1.06%.
Welcure Drugs & Pharmaceuticals Limited's Key Ratios
Welcure Drugs & Pharmaceuticals Limited has a market cap of ₹27.56 million, indicating a price to book ratio of 77.8458 and a price to sales ratio of 26.3783.
In the last 12-months Welcure Drugs & Pharmaceuticals Limited’s revenue was ₹913000 with a gross profit of ₹825000 and an EBITDA of ₹0. The EBITDA ratio measures Welcure Drugs & Pharmaceuticals Limited's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Welcure Drugs & Pharmaceuticals Limited’s operating margin was 1.1% while its return on assets stood at 1.64% with a return of equity of 5.73%.
In Q3, Welcure Drugs & Pharmaceuticals Limited’s quarterly earnings growth was a positive 0% while revenue growth was a positive 1%.
Welcure Drugs & Pharmaceuticals Limited’s PE and PEG Ratio
- Forward PE
- 0
- Trailing PE
- 643.3333
- PEG
Its diluted EPS in the last 12-months stands at ₹0.002 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of . A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Welcure Drugs & Pharmaceuticals Limited’s profitability.
Welcure Drugs & Pharmaceuticals Limited stock is trading at a EV to sales ratio of 31.4259 and a EV to EBITDA ratio of 1619.0816. Its price to sales ratio in the trailing 12-months stood at 26.3783.
Welcure Drugs & Pharmaceuticals Limited stock pays annual dividends of ₹ per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- ₹14.94 million
- Total Liabilities
- ₹1.44 million
- Operating Cash Flow
- ₹0.00
- Capital Expenditure
- ₹0
- Dividend Payout Ratio
- 0%
Welcure Drugs & Pharmaceuticals Limited ended 2024 with ₹14.94 million in total assets and ₹0 in total liabilities. Its intangible assets were valued at ₹14.94 million while shareholder equity stood at ₹13.51 million.
Welcure Drugs & Pharmaceuticals Limited ended 2024 with ₹0 in deferred long-term liabilities, ₹1.44 million in other current liabilities, 134391000.00 in common stock, ₹-120884000.00 in retained earnings and ₹0 in goodwill. Its cash balance stood at ₹14.64 million and cash and short-term investments were ₹14.64 million. The company’s total short-term debt was ₹0 while long-term debt stood at ₹0.
Welcure Drugs & Pharmaceuticals Limited’s total current assets stands at ₹14.64 million while long-term investments were ₹0 and short-term investments were ₹0. Its net receivables were ₹0 compared to accounts payable of ₹0 and inventory worth ₹0.
In 2024, Welcure Drugs & Pharmaceuticals Limited's operating cash flow was ₹0.00 while its capital expenditure stood at ₹0.
Comparatively, Welcure Drugs & Pharmaceuticals Limited paid ₹0 in dividends in 2024.
Other key metrics
- Current Trading Price
- ₹3.8
- 52-Week High
- ₹10.95
- 52-Week Low
- ₹3.31
- Analyst Target Price
- ₹
Welcure Drugs & Pharmaceuticals Limited stock is currently trading at ₹3.8 per share. It touched a 52-week high of ₹10.95 and a 52-week low of ₹10.95. Analysts tracking the stock have a 12-month average target price of ₹.
Its 50-day moving average was ₹3.84 and 200-day moving average was ₹4.35 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4207.4% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Welcure Drugs & Pharmaceuticals Limited
Similar Industry Stocks (Other)
Most Active
Top Gainers
Top Losers
About
Welcure Drugs & Pharmaceuticals Limited engages in the wholesale of pharmaceutical and medical goods in India. The company was incorporated in 1996 and is based in Delhi, India.